Wockhardt in talks with global vaccine firms for contract manufacturing

UK site would fill-finish 100 mn doses of AstraZeneca vaccine, has 350 mn dose capacity; Aurangabad can make has 1 bn doses, vaccine raw materials

Mumbai-based drugmajor Wockhardt said it is in talks with global vaccine makers for contract manufacturing drug substances for making vaccines as well as do the fill and finish doses out of its Indian site which has a capacity for one billion doses annually. 

Drug substances are the raw material for making vaccines. 

Meanwhile, the UK government has already reserved one fill and finish production line the company has in the UK for its exclusive use for 18 months in order to guarantee the supply of vaccines required to fight against COVID-19, the company said. This would be a fill and